Ποια είναι η κεφαλαιοποίηση αγοράς για HPGC Renmintongtai Pharmaceutical Corporation (600829)

Η κεφαλαιοποίηση αγοράς για HPGC Renmintongtai Pharmaceutical Corporation (600829) είναι $866.39M

HPGC Renmintongtai Pharmaceutical Corporation (600829) Τιμή και Κεφαλαιοποίηση Αγοράς

Q: Ποια είναι η τιμή για HPGC Renmintongtai Pharmaceutical Corporation (600829)

Η τιμή για HPGC Renmintongtai Pharmaceutical Corporation (600829) είναι $1.49

HPGC Renmintongtai Pharmaceutical Corporation is a pharmaceutical enterprise actively involved in the wholesale and retail distribution of diverse medicinal products across China and internationally. Its extensive product portfolio encompasses traditional Chinese medicines, herbal remedies, chemical preparations, antibiotics, biologics, biochemical drugs, medical equipment, and health-related items. The company also extends its operations to include logistics services, specifically warehousing and distribution. Additionally, it offers comprehensive hospital services covering medical treatment, scientific research, disease prevention, health promotion, rehabilitation, blood purification, and renal disease management. Through its e-commerce platform, HPGC Renmintongtai markets a broad selection of items, including Chinese and Western pharmaceuticals, traditional Chinese herbs, nutritional supplements, medical devices, cosmetics, and everyday necessities. The company maintains a significant retail presence with 319 chain stores located throughout Heilongjiang Province. Established in 1950 and headquartered in Harbin, China, HPGC Renmintongtai Pharmaceutical Corporation operates as a subsidiary of Harbin Pharmaceutical Group Co., Ltd.

Η τιμή για 600829	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$9,077.38 $866.39M	NVDA	$5.264T	+607,463.57%
$8,107.21 $866.39M	AAPL	$4.701T	+542,528.37%
$7,203.41 $866.39M	GOOG	$4.177T	+482,036.17%
$6,582.99 $866.39M	MSFT	$3.817T	+440,510.21%
$4,942.91 $866.39M	AMZN	$2.866T	+330,736.93%

Η τιμή για 600829

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$9,077.38 $866.39M